Atlas Trials

Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

Clinical trial NCT00416533 · COMPLETED

Trial details

NCT number
NCT00416533
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2004-08-01
Primary completion
2006-10-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.